Delivery Order 36C26126D0004-36C26126N0041
- Not listed
- This is a federal contract award to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $875,220.60, is a Firm Fixed Price Delivery Order awarded by the U.S. Department of Veterans Affairs (VA) through the Veterans Integrated Service Network 9. The contract is not set aside and will run through September 30, 2023. Roche Diagnostics is a global...
- This is a federal contract award to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $265,687.25, is a Delivery Order awarded by the Department of Veterans Affairs (VA) for the Veterans Integrated Service Network 9. It is a firm fixed-price contract with a period of performance ending on September 30, 2026. The contract does not have a...
- The Department of Veterans Affairs Veterans Health Administration awarded a $458,322.56 firm-fixed-price delivery order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for molecular pathology products and services. The contract does not have a set-aside designation. Roche Diagnostics is a foreign-owned, for-profit manufacturer that has provided medical equipment, reagents, and laboratory services to various federal agencies through prime contracts and subcontracts,...
- The Department of Veterans Affairs Veterans Health Administration awarded a Delivery Order contract to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The $342,604.03 Firm Fixed Price contract is for the supply of ROCHE EQUIPMENT SUPPLIES AND REAGENT and has a completion date of September 30, 2023. The contract is not set aside for any socioeconomic category. Roche Diagnostics holds several Indefinite Delivery Contracts and...
- The Department of Veterans Affairs Veterans Health Administration has awarded a $23,741.00 Firm Fixed Price Delivery Order contract to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment. This contract is for the provision of coagulation testing supplies to support VA healthcare facilities. The contract has no set-aside designation and a completion date of January 31, 2024. Roche Diagnostics holds several Indefinite...
- This federal contract award to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, is a Firm Fixed Price Delivery Order with a ceiling value of $240,369.00. The contract was awarded by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 9. The contract does not have a set-aside designation. Roche Diagnostics provides a comprehensive range of laboratory equipment, testing systems, reagents, and clinical testing...
- This is a delivery order contract awarded by the Veterans Integrated Service Network 23 (VISN 23), a component of the U.S. Department of Veterans Affairs (VA), to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $126,829.78, is for the provision of Roche testing supplies. It is not designated as a set-aside contract. The contract is part of a...
- This is a federal delivery order contract awarded by the Veterans Integrated Service Network 4 (VISN 4), a civilian agency within the Department of Veterans Affairs (VA), to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and medical equipment. The $343,594.91 firm-fixed-price contract is for IT equipment and has an ultimate completion date of April 30, 2029. It was awarded on May 1, 2024 and is not designated as a set-aside. Roche...
- The Department of Veterans Affairs (VA) awarded a $132,686.76 firm-fixed-price delivery order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The contract, which was not set aside, was issued under the VA's Veterans Integrated Service Network 12 and will provide molecular pathology services to support the VA's COVID-19 response efforts. Roche Diagnostics has a history of supplying critical medical equipment,...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 awarded a firm fixed-price delivery order contract worth $13,320.50 to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for coagulation testing and does not have a set-aside designation. Roche Diagnostics has a history of providing critical care analyzers,...
- 36C26126D0004Indefinite Delivery Contract
- 36C26126D0004-36C26126N0041Delivery Order
This is a delivery order awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $424,086.16, provides diagnostic equipment, consumable supplies, and testing kits to the VA's Veterans Integrated Service Network 21 for the period of October 1, 2025 to September 30, 2026. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Roche Diagnostics holds multiple significant Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) with federal agencies, including the Defense Health Agency and the VA, for a range of medical diagnostic technologies and services, often leveraging GSA schedule contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $424.1k | 10/1/25 |